butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide has been researched along with cholecystokinin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, D; Davidowa, H; Gabriel, HJ; Henklein, P; Müller, R; Zippel, U | 1 |
| Bohme, A; Boudeau, P; Corringer, PJ; Ducos, B; Durieux, C; Roques, BP; Weng, JH | 1 |
| Bourin, M; Kõks, S; Männistö, PT; Soosaar, A; Ustav, M; Vasar, E; Võikar, V; Volke, V | 1 |
3 other study(ies) available for butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide and cholecystokinin
| Article | Year |
|---|---|
Cholecystokinin-induced activity changes of dorsal lateral geniculate neurons in rats.
Topics: Animals; Cholecystokinin; Geniculate Bodies; Iontophoresis; Male; Neurons; Rats; Rats, Wistar; Receptors, Cholecystokinin; Sincalide; Tetragastrin | 1994 |
CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives.
Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Brain; Cholecystokinin; Guinea Pigs; Male; Molecular Sequence Data; Peptide Fragments; Phenylurea Compounds; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Structure-Activity Relationship; Tetragastrin | 1993 |
Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.
Topics: Animals; Anxiety; Ceruletide; Cholecystokinin; Disease Models, Animal; Drug Synergism; Exploratory Behavior; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetragastrin | 1998 |